Selective allosteric inhibition of cystathionine GAMMA-lyase as a broad anticancer strategy
Nitric Oxide · 2026-07 · 163 · S7
DOI: 10.1016/j.niox.2026.05.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nitric Oxide, 2026-07. Verfasst von Maureen Brusco und 13 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Brusco, M., Shatalin, K., Noothanaganti, A., Morningstar, T., Mateos, M. A., Kaushik, A., Wang, K., Wang, Z., Kim, C., Placantonakis, D., Pacold, M., Lechpammer, M., Serganov, A., & Nudler, E. (2026). Selective allosteric inhibition of cystathionine GAMMA-lyase as a broad anticancer strategy. Nitric Oxide, 163, S7. https://doi.org/10.1016/j.niox.2026.05.008
Vancouver
Brusco M, Shatalin K, Noothanaganti A, Morningstar T, Mateos MA, Kaushik A, et al. Selective allosteric inhibition of cystathionine GAMMA-lyase as a broad anticancer strategy. Nitric Oxide. 2026;163:S7. doi:10.1016/j.niox.2026.05.008
BibTeX
@article{Brusco2026,
author = {Brusco, Maureen and Shatalin, Konstantin and Noothanaganti, Ashok and Morningstar, Taryn and Mateos, Maria Ariza and Kaushik, Abhishek and Wang, Katie and Wang, Zixuan and Kim, Claire and Placantonakis, Dimitris and Pacold, Michael and Lechpammer, Mirna and Serganov, Alexander and Nudler, Evgeny},
title = {Selective allosteric inhibition of cystathionine GAMMA-lyase as a broad anticancer strategy},
journal = {Nitric Oxide},
year = {2026},
volume = {163},
pages = {S7},
doi = {10.1016/j.niox.2026.05.008}
}
EUVIMED